# Elanco Animal Health Incorporated (ELAN)

- Sector: Healthcare · Industry: Drug Manufacturers Specialty and Generic
- SEC CIK: 0001739104 ([filings on EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001739104))
- Full page: https://inspectstocks.com/stocks/elan
- Data as of: price 2026-09-28; newest filing used 2026-08-05; latest fiscal period ended 2026-06-30

## Grade

**A** on the growth-and-cash rubric, 5 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Revenue growing overall | passed | $5B | $4.3B |
| Revenue growing recently | passed | $5B | $4.7B |
| Free cash flow positive | passed | $379M |  |
| Free cash flow growing overall | passed | $379M | -$74M |
| Free cash flow growing recently | passed | $379M | $284M |

Business quality (the + / − mark): 2 of 5 checks passed.

| Check | Result | Now | Before |
| --- | --- | --- | --- |
| Profitable | failed | -4.0% |  |
| Healthy profit margin | failed | -4.0% |  |
| Good return on equity | failed | -3.0% |  |
| Debt under control | passed | 0.67 |  |
| Turns sales into cash | passed | 7.5% |  |

How the grade works: the letter counts failed checks (none → A, one → B, two → C, three → D, four or more → F). It is built from SEC filings only — the share price never enters it — and describes the business, not whether the stock is worth buying.

## Key figures

In US dollars, as filed.

| Measure | Value |
| --- | --- |
| Revenue, trailing twelve months | $5B |
| Net income, trailing twelve months | -$199M |
| Free cash flow, trailing twelve months | $379M |
| Net margin | -4.0% |
| Return on equity | -3.0% |
| Debt to equity | 0.67 |
| Diluted EPS, trailing twelve months | -$0.41 |
| Share price | $22.45 |
| Market value | $11.2B |
| Price / sales | 2.2x |

## More on this company

- [Overview](https://inspectstocks.com/stocks/elan)
- [Financial statements](https://inspectstocks.com/stocks/elan/financials)
- [Competitors](https://inspectstocks.com/stocks/elan/peers)
- [Earnings](https://inspectstocks.com/stocks/elan/earnings)

---

Source: InspectStocks, built from the company’s own SEC filings. This describes a business — it is not investment advice and not a recommendation to buy or sell anything.